ASCO24: Novartis’ Kinase Inhibitor Aces Phase III Against Leukemia
Pictured: Oncology tracker over the Chicago skyline/ Nicole Bean for BioSpace The American Society of Clinical Oncology (ASCO)’s annual meeting kicks off Friday in Chicago, with more than 5,000 abstracts highlighting investigational therapies for …